52w high/low | ₹524.9 / ₹116.25 |
P/E ratio | 5.81 |
Dividend | 0.22 |
ROE | 26.34 |
ROCE | 29.05 |
Face value | 10 |
Book value | ₹200.98Cr |
Market capital | ₹141.55Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Samrat Pharmachem Ltd is planning to de-merge its Second Unit in favour of newly formed company viz. Samrat Remedies Ltd w.e.f. April 1, 2004.